Selank + Semax
A commonly discussed research pairing of two Russian-developed nootropic peptides, combining an anxiolytic peptide with a neurotrophic/cognitive-effects peptide.
Rationale
Complementary CNS profiles (Selank anxiolytic; Semax neurotrophic/cognitive). Combined-use evidence is limited and preclinical.
Selank
Anxiolytic heptapeptide analog of tuftsin, proposed to modulate GABA and monoamine activity alongside immunomodulatory effects.
Commonly cited non-clinical intranasal range — NOT validated
- Dose
- 250–500 mcg
- Frequency
- daily (anecdotal)
Semax
ACTH(4-10) analog studied for neurotrophic (BDNF-linked) and cognitive effects; often paired with Selank to balance its more stimulating profile with Selank's anxiolytic effect.
Commonly cited non-clinical intranasal range — NOT validated
- Dose
- 300–600 mcg
- Frequency
- daily (anecdotal)
For research and educational purposes only. This is not medical advice. Neither peptide is FDA-approved. Consult a licensed healthcare provider before using any peptide.